Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy

AIMS: Exogenous atrial natriuretic peptide (ANP) may be a logical treatment for heart failure (HF) patients with ANP deficiency. Lower ANP concentrations may result from HF with preserved ejection fraction (HFpEF), which also results in lower brain natriuretic peptide levels in HFpEF relative to HF...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Matsumoto, Shingo, Nakazawa, Gaku, Ohno, Yohei, Ishihara, Mai, Sakai, Katsuaki, Nakamura, Norihito, Murakami, Tsutomu, Natsumeda, Makoto, Kabuki, Takayuki, Shibata, Atsushi, Kida, Keisuke, Konishi, Masaaki, Ishii, Shunsuke, Ikeda, Takanori, Ikari, Yuji
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7754892/
https://ncbi.nlm.nih.gov/pubmed/33037750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados